Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46.4M
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
43.2M
-
Shares change
-
+363K
-
Total reported value, excl. options
-
$687M
-
Value change
-
+$2.4M
-
Put/Call ratio
-
0.95
-
Number of buys
-
112
-
Number of sells
-
-105
-
Price
-
$15.92
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q4 2024
296 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q4 2024.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.2M shares
of 46.4M outstanding shares and own 93.05% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.15M shares), VANGUARD GROUP INC (5.34M shares), T. Rowe Price Investment Management, Inc. (3.01M shares), RGM Capital, LLC (2.99M shares), DIMENSIONAL FUND ADVISORS LP (2.58M shares), STATE STREET CORP (1.96M shares), BROWN ADVISORY INC (1.91M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.41M shares), Paradice Investment Management LLC (1.29M shares), and WESTWOOD HOLDINGS GROUP INC (1.26M shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.